Brain Cancer Drugs Market Research Reports

Global Brain Cancer Partnering 2012 to 2018 - Product Thumbnail Image

Global Brain Cancer Partnering 2012 to 2018

  • Report
  • 150 Pages
From
Brain & CNS Cancer Forecast in 19 Major Markets 2016-2026 - Product Thumbnail Image

Brain & CNS Cancer Forecast in 19 Major Markets 2016-2026

  • Report
  • 66 Pages
From
CAS 50-18-0 Cyclophosphamide Chemical World Report - Product Thumbnail Image

CAS 50-18-0 Cyclophosphamide Chemical World Report

  • Report
  • 2011 Pages
CAS 59-05-2 Methotrexate Chemical World Report - Product Thumbnail Image

CAS 59-05-2 Methotrexate Chemical World Report

  • Report
  • 2111 Pages
CAS 6055-19-2 Cyclophosphamide monohydrate Chemical World Report - Product Thumbnail Image

CAS 6055-19-2 Cyclophosphamide monohydrate Chemical World Report

  • Report
  • 2001 Pages
CAS 7413-34-5 Sodium methotrexate Chemical World Report - Product Thumbnail Image

CAS 7413-34-5 Sodium methotrexate Chemical World Report

  • Report
  • 2006 Pages
Oligodendroglioma R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Oligodendroglioma R&D Pipeline Analysis Report, H2-2018

  • Report
  • 120 Pages
From
Recurrent Malignant Glioma R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Recurrent Malignant Glioma R&D Pipeline Analysis Report, H2-2018

  • Report
  • 40 Pages
From
Anaplastic Oligoastrocytoma R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Anaplastic Oligoastrocytoma R&D Pipeline Analysis Report, H2-2018

  • Report
  • 60 Pages
From
Meningioma R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Meningioma R&D Pipeline Analysis Report, H2-2018

  • Report
  • 200 Pages
From
Pontine Glioma R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Pontine Glioma R&D Pipeline Analysis Report, H2-2018

  • Report
  • 210 Pages
From
Medulloblastoma R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Medulloblastoma R&D Pipeline Analysis Report, H2-2018

  • Report
  • 160 Pages
From
Gliosarcoma R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Gliosarcoma R&D Pipeline Analysis Report, H2-2018

  • Report
  • 210 Pages
From
Anaplastic Astrocytoma R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Anaplastic Astrocytoma R&D Pipeline Analysis Report, H2-2018

  • Report
  • 130 Pages
From
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) R&D Pipeline Analysis Report, H2-2018

  • Report
  • 120 Pages
From
Ependymoma R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Ependymoma R&D Pipeline Analysis Report, H2-2018

  • Report
  • 120 Pages
From
CAS 15663-27-1 Cisplatin Chemical World Report - Product Thumbnail Image

CAS 15663-27-1 Cisplatin Chemical World Report

  • Report
  • 2157 Pages
CAS 159351-69-6 Everolimus Chemical World Report - Product Thumbnail Image

CAS 159351-69-6 Everolimus Chemical World Report

  • Report
  • 2075 Pages
CAS Cyclophosphamide World Consumption Report - Product Thumbnail Image

CAS Cyclophosphamide World Consumption Report

  • Report
  • 2091 Pages
CAS Methotrexate World Consumption Report - Product Thumbnail Image

CAS Methotrexate World Consumption Report

  • Report
  • 2095 Pages
Loading Indicator

With low survival rates primary brain cancers such as glioblastoma multiforme (the most common and aggressive of malignant brain tumours) are among the deadliest forms of cancer. Drug development activity is therefore intense in this sector, with resulting business development opportunities. Reports in the Brain Cancer section enable you to explore various facets of the industry from a variety of expert viewpoints, including R&D (clinical trials, drug discovery, etc.), competitive landscape, supply and demand, regional markets, regional market analysis, and much more. Show Less Read more

adroll